罗氏报告BTK抑制剂在多发性硬化症三期试验中取得突破，成功超越竞争对手——Fierce Biotech报道

Roche reports phase 3 multiple sclerosis wins for BTK inhibitor, succeeding where rivals failed  Fierce Biotech